BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
England and Wales High Court (Chancery Division) Decisions |
||
You are here: BAILII >> Databases >> England and Wales High Court (Chancery Division) Decisions >> The Competition And Markets Authority (CMA) v Concordia International Rx (UK) Ltd [2018] EWHC 3448 (Ch) (12 December 2018) URL: http://www.bailii.org/ew/cases/EWHC/Ch/2018/3448.html Cite as: [2018] EWHC 3448 (Ch) |
[New search] [Printable PDF version] [Help]
BUSINESS AND PROPERTY COURTS OF ENGLAND AND WALES
COMPETITION LIST (ChD)
Rolls Building 7 Rolls Building Fetter Lane London EC4A 1NL |
||
B e f o r e :
____________________
THE COMPETITION AND MARKETS AUTHORITY |
Claimant |
|
- and – |
||
CONCORDIA INTERNATIONAL RX (UK) LIMITED |
Defendant |
____________________
Mr Mark Brealey, QC (instructed by Morgan, Lewis and Bockius UK LLP) for the Defendant
Hearing date: 5 December 2018
____________________
Crown Copyright ©
Mr Justice Marcus Smith:
A. INTRODUCTION
(1) Carbimazole 5mg and 20mg tablets ("Carbimazole"); and
(2) Hydrocortisone 10mg tablets ("Hydrocortisone").
B. THE CONTEXT
(1) The general rule is that the court should consider first representations by the party asserting PII (in this case, the CMA), then by the party the subject of the warrant (Concordia) in "open" proceedings, then further representations by the party asserting PII in the subject's absence in "closed" proceedings: Commissioner of Police for the Metropolis v. Bangs [2014] EWHC 546 (Admin) ("Bangs") at [31].
(2) So far as possible, purely legal matters should be resolved in the "open" proceedings: Bangs at [32].
(3) Where it is necessary to hold "open" and "closed" hearings, the judge must give "open" and "closed" judgments. It is highly desirable, in the "open" judgment, to identify every conclusion in that judgment which has been reached in whole or in part in the light of points made in evidence referred to in the "closed" judgment and state that this is what has been done: Bank Mellat v. HM Treasury (No 2) [2013] UKSC 38 at [68].
C. THE CMA'S ASSERTION OF PUBLIC INTEREST IMMUNITY
(1) The sensitive material
(1) The first affidavit of Ms Ann Pope, the Senior Director for Anti-Trust Enforcement in the CMA, sworn on 29 September 2017 ("Pope 1"). Pope 1 attached one exhibit ("Pope 1 Exhibit").
(2) The first affidavit of Mr Andrew Groves, a Director in the Competition, Consumer and Markets Group in the Enforcement Directorate of the CMA, sworn 29 September 2017 ("Groves 1"). Groves 1 attached one exhibit ("Groves 1 Exhibit").
(3) The first affidavit of Ms Susan Oxley, Project Director, Competition, Consumer and Markets Group at the CMA, sworn 29 September 2017 ("Oxley 1"). Oxley 1 attached one exhibit ("Oxley 1 Exhibit").
(4) The first affidavit of "X" (the name of the deponent is redacted on grounds of PII), sworn 29 September 2017 ("X 1"). X 1 attached one exhibit ("X 1 Exhibit").
(5) The CMA's skeleton argument in support of its application for the Warrant before Mann J (the "CMA Skeleton").
(6) A transcript of the ex parte hearing before Mann J on 5 October 2017 (the "Transcript").
(7) The judgment of Mann J – Neutral Citation [2017] EWHC 2577 (Ch) – in which he determined the CMA's application.
(1) As the CMA considered necessary in the public interest; and
(2) For relevance.
(2) The basis for the assertion of PII by the CMA
(3) The test for upholding an assertion of PII
"There are two aspects of the public interest which pull in contrary directions. It is in the public interest that full effect should be given to the normal rights of a litigant. It is in the public interest that in the determination of disputes the courts should have all relevant material before them. It is, on the other hand, in the public interest that material should be withheld if, by its production and disclosure, the safety or well-being of the community would be adversely affected. There will be situations in which a decision ought to be made whether the harm that may result from the production of documents will be greater than the harm that may result from their non-production."
(1) Whether the evidence in relation to which PII is asserted is relevant to an issue in the proceedings.
(2) Whether disclosure of that evidence would cause harm to the public interest.
(3) If so, whether, balancing the public interest in the administration of justice against the harm to the public interest that would be occasioned by disclosure, an order for disclosure should be made.
(1) It seemed to be clear law that when considering an assertion of PII the court should "not merely consider whether the immunity is well founded but also…assess how the issue can be resolved fairly. For this purpose, the court will wish to consider whether the position can be resolved by ordering disclosure on terms which protect the public interest".[6]
(2) Thus, in Conway v. Rimmer itself, Lord Pearce contemplated masking or sealing up certain parts of documents and only disclosing the rest:[7]
"If part of a document is innocuous but part is of such a nature that its disclosure would be undesirable, it should seal up the latter part and order discovery of the rest, provided that this will not give a distorted or misleading impression. In all these matters it must consider the public interest as a whole, giving due weight both to the administration of the executive and to the administration of justice."
It will be observed that this was the course followed in the present case: as I have described, the CMA disclosed to Concordia the Section 28 Application Materials, subject to the Relevance Redactions and the PII Redactions.
(3) By the same measure, it is incumbent on the court to consider whether relevant extracts can be disclosed or a summary made of the relevant material. In R v. Chief Constable of West Midlands Police, ex parte Wiley [1995] 1 AC 274 at 306-307, Lord Woolf stated (emphasis supplied):
"If the legal advisers of a party, who is in possession of material which is the subject of immunity from disclosure, is aware of the contents of that material, they will be in a better position to perform what they should consider to be their duty, that is to assist the court and the other party to mitigate any disadvantage which results from the material being not disclosed. It may be possible to provide any necessary information without producing the actual document. It may be possible to disclose a part of the document or a document on a restricted basis. An assurance may be accepted by counsel. In many cases, co-operation between the legal advisers of the parties should avoid the risk of injustice. There is usually a spectrum of action which can be taken if the parties are sensible which will mean that any prejudice due to non-disclosure of the documents is reduced to a minimum."
(4) The underlined words appear to suggest that disclosure of a PII document may be limited to solicitors and counsel, which is the view expressed by Hollander.[8] That course comes very close to the creation of a confidentiality ring, which was an approach considered by the Court of Appeal in Concordia and rejected by it. The basis upon which the Court of Appeal rejected the use of confidentiality rings was not (or not only) because of their inherent unsuitability in PII Cases[9] but because "once a court has held that material is protected by PII it cannot be disclosed, whether into a confidentiality ring or otherwise".[10]
(5) I doubt whether this injunction against disclosure prohibits the redaction of PII materials so as to excise the sensitive parts, or to the provision of a summary or gist, not least because that has been accepted practice since at least Conway v. Rimmer and was the process adopted in this case by the CMA. However, it does seem to me to preclude the use of forms of process (such as confidentiality rings) which involves the disclosure of PII material, but under a special process designed to protect the public interest. In such cases, the only proper process is a "closed material process".[11]
Accordingly, even if I had concluded (which I did not) that there was some "third way" which would have allowed the disclosure of PII Redactions whilst sufficiently protecting the public interest in keeping such material under wraps, that is a course that would not have been open to me for the reasons given by the Court of Appeal in Powell v. Chief Constable of North Wales Constabulary and Concordia.
(1) The seriousness of the matter before me. Obviously, the question of whether the Warrant was properly granted or should be varied is an important one. Section 28 warrants are intrusive, and the right of the subject of the warrant to mount a challenge is an important one. However, on the scale of significance, an application to set aside a section 28 warrant does not involve the liberty of the subject. Nor does it involve the invasion of personal privacy[12] or of a private home. It involves the searching of business premises. Thus, whilst I consider that the present case ranks well-above proceedings where only damages are being claimed, it ranks below cases where the liberty of the subject is at stake because the PII material being withheld is relevant to the outcome of a criminal trial.
(2) On the facts of the present case, the Warrant would have been executed in any event. As I have noted, Concordia's challenge is only in relation to Carbimazole and Hydrocortisone. To the extent that the Warrant applies to other relevant products, it stands without challenge. It follows, therefore, that – whether the Warrant is justified in relation to Carbimazole and Hydrocortisone or not – a section 28 warrant would have been executed against Concordia in any event. This does seem to me to be a significant factor limiting the adverse effects of granting PII to the PII Redactions.[13]
(3) Prejudice to Concordia in vindicating its rights. As to this:
(a) As counsel for the CMA pointed out, in my earlier decision in these proceedings ([2017] EWHC 2911 (Ch) at [64]), I expressed myself in fairly trenchant terms:
"Al Rawi made clear that a "closed material" process requires legislative underpinning. That is both because such a process is intrinsically unfair – because it eschews the level playing field that is the hallmark of a fair litigation process – and because the process has the significant disadvantage of impairing the perceived independence of the judiciary…It is not right – unless stipulated by legislation – that a judge be placed in the position of having to send a party out of a courtroom, and then hand down a decision against that party based or apparently based on material not seen by that party."
(b) I erred in my conclusion that a "closed material procedure" requires legislative underpinning, as the Supreme Court's decision in Haralambous shows, and my decision was rightly overturned by the Court of Appeal in Concordia as a result. In highlighting this passage in his submissions before me, Mr Beer, QC – quite properly – was making the point that I could not allow the concerns I had articulated to prevent the due operation of a "closed material procedure". That is obviously right. I cannot allow the general concerns articulated in my decision at [64] to automatically outweigh the interest in protecting PII Material through a "closed material procedure".
(c) However, I can properly consider the extent to which the due administration of justice is impaired by one party having material that the other does not. The extent will vary from case to case, depending upon the complexity of the issues, and the importance of the PII Material to those issues.
(d) In this case, the PII Material is fairly central to considering the validity or otherwise of the Warrant, and Mr Brealey, QC, who acts for Concordia, will obviously be materially impaired in the submissions he will be able to make. That said, Mr Brealey, QC has been able to articulate – and will no doubt further articulate before the hearing on 19 December 2018 – the sort of points he would like to make and which the court should be astute to probe with the CMA. Equally, I do not consider that I am, in this case, impaired from probing the CMA in relation to the PII Redactions by the fact that I am also the judge in the proceedings. The CMA have made it clear that they expect such probing and are prepared to provide the sort of assistance to me that would normally be unnecessary because it would be done by Mr Brealey, QC and his team. I also take into account that a "closed material process" places upon the CMA the duty of full and frank disclosure that exists in normal ex parte applications.
(1) The name of the deponent and the deponent's position within the CMA, which has been redacted on PII grounds in X 1 and the other Section 28 Application Materials is not protected by PII and should be disclosed.
(2) Everything else in the PII Redactions, however, is properly protected by PII and cannot be disclosed in "open" proceedings.
Note 1 The reason for the delay between the issuing of the application on 10 October 2017 and the intended hearing of that application on 19 December 2018 was the appeal of my decision at [2017] EWHC 2911 (Ch) to the Court of Appeal. That appeal could not be heard – although expedited – until the Supreme Court’s decision in Haralambous was handed down. [Back] Note 2 Thus, Haralambous has succeeded in creating, through the common law, a procedure similar to the statutory procedures protecting material the disclosure of which would be damaging to the interests of national security. These procedures are provided for in sections 6ff of the Justice and Security Act 2013 and CPR Part 82. [Back] Note 3 The CMA did not oppose the making of this order. The process that has been followed tracks CPR Part 31.19, but (in this case) there was no list of documents, given the nature of the hearing before Mann J. It was therefore necessary – in order to understand the issues between the parties – for the Section 28 Application Materials to be disclosed to the extent this could be done consistently with the public interest. [Back] Note 4 See R v Davis [1993] 1 WLR 613 at 617 (per Lord Taylor CJ); R v. H [2004] UKHL at [20] (per Lord Bingham). [Back] Note 5 This sort of scrutiny is very important in reaching properly founded decisions. See, for example, the research described in Haidt, The Righteous Mind, 1st ed (2012) at 75-76. [Back] Note 6 Hollander, Documentary Evidence, 13th ed (2018) (“Hollander”) at [22-09]. [Back] Note 7 [1968] 1 AC 910 at 988. [Back] Note 8 At [22-09]. Hollander cites Science Research Council v. Nassé [1980] AC 1028 at 1077 (per Lord Edmund Davies, citing Lord Denning MR at [1979] 1 QB 144 at 173). However, Nassé was not a PII case, and is of limited assistance here. [Back] Note 9 Concordia at [39]. [Back] Note 10 Concordia at [71]. [Back] Note 11 Thus, in the unreported case of Powell v. Chief Constable of North Wales Constabulary (Court of Appeal, 16 December 1999), the judge at first instance found that material in a civil case was protected by PII, but he devised a procedure whereby the PII Material could be usedin camera. Although Schiemann LJ rejected this procedure and allowed the appeal on the grounds that it did not sufficiently protect the PII Material in question, Roch and Beldam LJJ concluded that “the judge has no residual discretion once he has determined that evidence concerning the informant should not be disclosed”. In short, once PII had been found to exist, the material had to be withheld from the court process. [Back] Note 12 Bangs involved the serious infringement of the liberty of the citizen, in that Ms Bangs was restrained in handcuffs and subjected to an intimate search. Nevertheless, the Court of Appeal made the point that this was less serious than a case where the liberty of the subject was at stake in a criminal trial. [Back] Note 13 The fact that, in relation to some of the relevant products, the CMA has concluded its investigations without taking further action is nothing to the point. The point is whether the Warrant was properly granted in the first place: so far as all relevant products apart from Carbimazole and Hydrocortisone are concerned, that is the case. [Back]